These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1931895)

  • 1. Flow cytometry of breast cancer.
    Feichter GE
    Zentralbl Pathol; 1991; 137(3):220-6. PubMed ID: 1931895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA image cytometry on machine-selected breast cancer cells and a comparison between flow cytometry and scanning cytophotometry.
    Cornelisse CJ; Van Driel-Kulker AM
    Cytometry; 1985 Sep; 6(5):471-7. PubMed ID: 4042787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
    Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
    Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures.
    Spyratos F; Briffod M
    Mod Pathol; 1997 Jun; 10(6):556-63. PubMed ID: 9195572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative DNA analysis of breast cancer by flow cytometry and image analysis.
    Borgiani L; Cogorno P; Toso F; Gallo L; Buccaran G; Rovida S; Canepa M
    Pathologica; 1994 Aug; 86(4):356-9. PubMed ID: 7535909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters].
    Araya JC; Roa I; Wistuba I; Villaseca MA; Contreras E; Olcese A; Danton A; Watanabe H
    Rev Med Chil; 1994 Jun; 122(6):643-52. PubMed ID: 7732208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA analysis by flow cytometry in breast carcinoma].
    Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R
    Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [S-phase fraction and proportion of cells with high DNA content as prognostic factors of lymph node negative breast cancer].
    Wagner T; Adler A; Kubista E
    Wien Klin Wochenschr; 1993; 105(24):712-4. PubMed ID: 8116307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometry-pathology combined study of breast cancer].
    Yu ZY; Yu JM; Wu TH; Zhuo PY; Wang SF; Li M; Zhang X; Lü BY; Liu YB
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):420-2. PubMed ID: 16188128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined image and flow cytometric DNA assessments in human breast cancer: a methodological study based on a routine histopathological material of 2024 excised tumour specimens.
    Falkmer UG; Hagmar T; Auer G
    Anal Cell Pathol; 1990 Sep; 2(5):297-312. PubMed ID: 2275876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
    Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
    Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer heterogeneity assessed by flow cytometry.
    Savarese A; Vecchione A
    In Vivo; 1993; 7(6B):631-4. PubMed ID: 8193285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].
    Jeanfaivre T; Chassevent A; Larra F; Tuchais E
    Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
    Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L
    Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in primary breast cancer.
    McGuire WL
    Cancer Surv; 1986; 5(3):527-36. PubMed ID: 3555781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.